Creating, facilitating and promoting sustainable Health Technology Assessment (HTA) cooperation in Europe

Publication of Project Plans

We are pleased to announce the Project Plans for the deliverables in the EUnetHTA 21 Service Contract (2021-2023) are published. They provide a general overview and describe the objectives, approach and timelines

Read More »
EUnetHTA 21

EUnetHTA 21

On 17 September 2021, the European Health and Digital Executive Agency (HaDEA) signed the Service Contract for the Provision of Joint Health Technology Assessment (HTA) Work

Read More »

Joint HTA Work

EUnetHTA develops several services that help inform the decision-making process around the introduction of pharmaceuticals and other technologies at the national, regional, and European levels. These include Joint Scientific Consultations, Parallel Consultations, and Post Launch Evidence Generation (PLEG). Find out more here.

Tools

EUnetHTA has developed a suite of tools to complement all steps in the collaborative joint work process, helping partners to proceed with a defined methodology. Access all current and archived tools here.

COVID-19 Response

EUnetHTA has prioritised COVID-19-related initiatives above other work during the current time. Here you will find updated information and publications relating to COVID-19 diagnostic testing, therapeutic treatments, and useful links to further data from our network partners.

Get Involved

EUnetHTA functions as a collaboration between network members and exterior partners to develop joint work. These include patients, industry, regulators, HCPs, and payers. Find out more about partner involvement, activities, and EUnetHTA events here.

Have questions? Check our FAQ